These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21235701)

  • 21. The bladder pain/interstitial cystitis symptom score: development, validation, and identification of a cut score.
    Humphrey L; Arbuckle R; Moldwin R; Nordling J; van de Merwe JP; Meunier J; Crook T; Abraham L
    Eur Urol; 2012 Feb; 61(2):271-9. PubMed ID: 22050826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total urgency and frequency score as a measure of urgency and frequency in overactive bladder and storage lower urinary tract symptoms.
    Chapple CR; Drake MJ; Van Kerrebroeck P; Cardozo L; Drogendijk T; Klaver M; Van Charldorp K; Hakimi Z; Compion G
    BJU Int; 2014 May; 113(5):696-703. PubMed ID: 24712917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison study of two lower urinary tract symptoms screening tools in clinical practice: the B-SAQ and OAB-V8 questionnaires.
    Basra RK; Cortes E; Khullar V; Kelleher C
    J Obstet Gynaecol; 2012 Oct; 32(7):666-71. PubMed ID: 22943714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nocturia in patients with overactive bladder.
    Espuña-Pons M; Blasco P; Pérez M; Rebollo P
    Arch Esp Urol; 2010 Jun; 63(5):363-72. PubMed ID: 20587841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bladder symptoms assessed with overactive bladder questionnaire in Parkinson's disease.
    Iacovelli E; Gilio F; Meco G; Fattapposta F; Vanacore N; Brusa L; Giacomelli E; Gabriele M; Rubino A; Locuratolo N; Iani C; Pichiorri F; Colosimo C; Carbone A; Palleschi G; Inghilleri M
    Mov Disord; 2010 Jul; 25(9):1203-9. PubMed ID: 20310046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. National community prevalence of overactive bladder in the United States stratified by sex and age.
    Coyne KS; Sexton CC; Vats V; Thompson C; Kopp ZS; Milsom I
    Urology; 2011 May; 77(5):1081-7. PubMed ID: 21256571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solifenacin treatment for overactive bladder in Hispanic patients: patient-reported symptom bother and quality of life outcomes from the VESIcare Open-Label Trial.
    Capo' JP; Laramée C; Lucente V; Fakhoury A; Forero-Schwanhaeuser S
    Int J Clin Pract; 2008 Jan; 62(1):39-46. PubMed ID: 18036164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluating patients' symptoms of overactive bladder by questionnaire: the role of urgency in urinary frequency.
    Mitchell SA; Brucker BM; Kaefer D; Aponte M; Rosenblum N; Kelly C; Hickling D; Nitti VW
    Urology; 2014 Nov; 84(5):1039-43. PubMed ID: 25443897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linguistic validation of the N-QOL (ICIQ), OAB-q (ICIQ), PPBC, OAB-S and ICIQ-MLUTSsex questionnaires in 16 languages.
    McKown S; Abraham L; Coyne K; Gawlicki M; Piault E; Vats V
    Int J Clin Pract; 2010 Nov; 64(12):1643-52. PubMed ID: 20722767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of overactive bladder on work productivity.
    Coyne KS; Sexton CC; Thompson CL; Clemens JQ; Chen CI; Bavendam T; Dmochowski R
    Urology; 2012 Jul; 80(1):97-103. PubMed ID: 22748868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of bladder diary with urinary perception to assess overactive bladder symptoms in community-dwelling women.
    Honjo H; Kawauchi A; Ukimura O; Nakao M; Kitakoji H; Miki T
    Neurourol Urodyn; 2009; 28(8):982-5. PubMed ID: 19267392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ).
    Matza LS; Thompson CL; Krasnow J; Brewster-Jordan J; Zyczynski T; Coyne KS
    Neurourol Urodyn; 2005; 24(3):215-25. PubMed ID: 15747340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in women.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    Eur Urol; 2009 Apr; 55(4):783-91. PubMed ID: 19157689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lower urinary tract symptoms: lack of change in prevalence and help-seeking behaviour in two population-based surveys of women in 1991 and 2007.
    Wennberg AL; Molander U; Fall M; Edlund C; Peeker R; Milsom I
    BJU Int; 2009 Oct; 104(7):954-9. PubMed ID: 19388983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of clinically meaningful overactive bladder: bother and quality of life results from the population-based FINNO study.
    Vaughan CP; Johnson TM; Ala-Lipasti MA; Cartwright R; Tammela TL; Taari K; Auvinen A; Tikkinen KA
    Eur Urol; 2011 Apr; 59(4):629-36. PubMed ID: 21306820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation study of the Self-Assessment Goal Achievement (SAGA) questionnaire for lower urinary tract symptoms.
    Brubaker L; Piault EC; Tully SE; Evans CJ; Bavendam T; Beach J; Yeh Y; Kopp ZS; Khullar V; Kelleher CJ; Trocio J
    Int J Clin Pract; 2013 Apr; 67(4):342-50. PubMed ID: 23521326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overactive bladder in Taiwanese women: re-analysis of epidemiological database of community from 1999 to 2001.
    Chen YC; Ng SC; Chen SL; Huang YH; Hu SW; Chen GD
    Neurourol Urodyn; 2012 Jan; 31(1):56-9. PubMed ID: 21826728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between improvements in symptoms and patient assessments of bladder condition, symptom bother and health-related quality of life in patients with overactive bladder treated with tolterodine.
    Coyne KS; Elinoff V; Gordon DA; Deng DY; Brodsky M; Glasser DB; Jumadilova Z; Carlsson M
    Int J Clin Pract; 2008 Jun; 62(6):925-31. PubMed ID: 18479285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
    Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
    J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.